Compare Ascendis Pharma A/S (ASND) vs Gigacloud Technology Inc (GCT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Gigacloud Technology Inc — how do they compare? Ascendis Pharma A/S trades at $255.51 (market cap $16.67B), while Gigacloud Technology Inc trades at $52 (market cap $1.84B). The key difference: Ascendis Pharma A/S is far larger — about 9.1× Gigacloud Technology Inc's market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, Ascendis Pharma A/S nearer its low. Which is the better fit depends on your goals.
| ASND | GCT | |
|---|---|---|
Market Cap | $16.67B | $1.84B |
Sector | Health | Technology |
52-Week High | $277.18 | $53.25 |
52-Week Low | $189.74 | $25.44 |
Enterprise Value | $17.04B | $1.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →
